Nanjing Daily reported on the National Center for Technology Transfer in Biomedicine using Eynos as a case study of how a doctoral project becomes a registered company.
This page summarises a media report about Eynos. Quoted wording — including terms such as "breakthrough", "on par with", "first" or "unique" — is the original reporter's language and is not a performance claim by the company. Product performance is defined by the manual and the measured data. All products are for research use only (RUO) and are not intended for diagnostic or therapeutic use.
The article follows the sequence from a research result at Nanjing University, through the branch centre's review, to incorporation and first product batches.
It notes the constraint that shapes this kind of spin-off: the founding team keeps the technical work while the centre supplies facilities, regulatory guidance and early customer access.
The full report is published in Chinese: 中文原文. This page is an English summary prepared by Eynos.
Tell us your cell type, sample source and downstream assay — we will suggest an isolation route, a culture condition and the matching catalogue numbers.